Yes, too much to ask lol
Even at 30c the directors purchases in the cr were the equivalent of someone average paying $5k in a cr which makes it look small in comparison to one in $1m pa
These options will never be converted let alone are meant to be converted and they're meant to make them look like they're incentivised to achieve those price increases
Another carrot dangled
- Forums
- ASX - By Stock
- Ann: Admedus Appoints Wayne Paterson as CEO
Yes, too much to ask lol Even at 30c the directors purchases in...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.68 |
Change
-0.320(2.67%) |
Mkt cap ! $246.9M |
Open | High | Low | Value | Volume |
$11.57 | $11.81 | $11.42 | $152.5K | 13.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 116 | $11.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.68 | 188 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 116 | 11.500 |
1 | 1000 | 11.400 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
2 | 1045 | 11.200 |
Price($) | Vol. | No. |
---|---|---|
11.680 | 188 | 1 |
11.700 | 1351 | 1 |
11.900 | 1000 | 1 |
12.000 | 4817 | 1 |
12.400 | 198 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online